Department of Otolaryngology-Head and Neck Surgery.
Program in Audiology and Communication Sciences, Department of Otolaryngology-Head and Neck Surgery.
Otol Neurotol. 2020 Oct;41(9):1190-1197. doi: 10.1097/MAO.0000000000002784.
Hearing loss remains a significant morbidity for patients with vestibular schwannomas (VS). A growing number of reports suggest audibility with cochlear implantation following VS resection; however, there is little consensus on preferred timing and cochlear implant (CI) performance.
A systematic literature search of the Ovid Medline, Embase, Scopus, and clinicaltrails.gov databases was performed on 9/7/2018. PRISMA reporting guidelines were followed.
Included studies reported CI outcomes in an ear that underwent a VS resection. Untreated VSs, radiated VSs, and CIs in the contralateral ear were excluded.
Primary outcomes were daily CI use and attainment of open-set speech. Baseline tumor and patient characteristics were recorded. Subjects were divided into two groups: simultaneous CI placement with VS resection (Group 1) versus delayed CI placement after VS resection (Group 2).
Twenty-nine articles with 93 patients met inclusion criteria. Most studies were poor quality due to their small, retrospective design. Group 1 had 46 patients, of whom 80.4% used their CI on a daily basis and 50.0% achieved open-set speech. Group 2 had 47 patients, of whom 87.2% used their CI on a daily basis and 59.6% achieved open-set speech. Group 2 had more NF2 patients and larger tumors. CI timing did not significantly impact outcomes.
Audibility with CI after VS resection is feasible. Timing of CI placement (simultaneous versus delayed) did not significantly affect performance. Overall, 83.9% used their CI on a daily basis and 54.8% achieved open-set speech.
听神经瘤(VS)患者仍存在听力损失这一重大发病率。越来越多的报告表明,在 VS 切除后进行耳蜗植入可以提高可听度;然而,对于最佳时机和耳蜗植入(CI)性能,目前仍缺乏共识。
2018 年 9 月 7 日,对 Ovid Medline、Embase、Scopus 和 clinicaltrails.gov 数据库进行了系统的文献检索。遵循 PRISMA 报告指南。
纳入的研究报告了接受 VS 切除术的耳朵的 CI 结果。未治疗的 VS、放射性 VS 和对侧耳朵中的 CI 被排除在外。
主要结果是日常 CI 使用和开放式语音的获得。记录了基线肿瘤和患者特征。受试者分为两组:VS 切除同时进行 CI 植入(组 1)与 VS 切除后延迟 CI 植入(组 2)。
符合纳入标准的 29 篇文章,共 93 例患者。由于其小样本、回顾性设计,大多数研究质量较差。组 1 有 46 例患者,其中 80.4%的患者每天使用 CI,50.0%的患者实现了开放式语音。组 2 有 47 例患者,其中 87.2%的患者每天使用 CI,59.6%的患者实现了开放式语音。组 2 有更多的 NF2 患者和更大的肿瘤。CI 时机并未显著影响结果。
VS 切除后使用 CI 实现可听度是可行的。CI 放置的时机(同时与延迟)并没有显著影响性能。总体而言,83.9%的患者每天使用 CI,54.8%的患者实现了开放式语音。